Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
13.99
-0.63 (-4.31%)
At close: Feb 21, 2025, 4:00 PM
13.89
-0.10 (-0.71%)
After-hours: Feb 21, 2025, 7:47 PM EST
Evolus Employees
Evolus had 273 employees as of December 31, 2023. The number of employees increased by 58 or 26.98% compared to the previous year.
Employees
273
Change (1Y)
58
Growth (1Y)
26.98%
Revenue / Employee
$909,619
Profits / Employee
-$203,150
Market Cap
885.87M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
EOLS News
- 2 days ago - Evolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit - Business Wire
- 4 days ago - Evolus to Report Fourth Quarter and Year End 2024 Results on March 4, 2025 - Business Wire
- 9 days ago - US FDA approves Evolus' anti-wrinkle gels - Reuters
- 9 days ago - Evolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels - Business Wire
- 15 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company's Guidance - Business Wire
- 5 weeks ago - Evolus: Still Bullish, But Business Faces Tricky Challenges In '25 - Seeking Alpha
- 3 months ago - Evolus, Inc. (EOLS) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha